Combined all‐trans retinoic acid with low‐dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single‐center, secondary analysis of a phase II study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined all‐trans retinoic acid with low‐dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single‐center, secondary analysis of a phase II study
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-02-03
DOI
10.1002/cam4.5653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adenoid cystic carcinoma: A review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy
- (2021) James Nightingale et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma.
- (2021) Martin McCarter et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
- (2021) Glenn J. Hanna et al. ORAL ONCOLOGY
- Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life
- (2020) Laura D. Locati et al. CANCER
- Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- (2020) Maria V. Yusenko et al. CANCER LETTERS
- The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype
- (2020) Luc GT Morris et al. CLINICAL CANCER RESEARCH
- Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study
- (2020) Ling Li et al. INVESTIGATIONAL NEW DRUGS
- Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells
- (2020) Xiaodan Sun et al. Oxidative Medicine and Cellular Longevity
- Apatinib Monotherapy for Chemotherapy-Refractory Metastatic Colorectal Cancer: A Multi-centre, Single-Arm, Prospective Study
- (2020) Fen Wang et al. Scientific Reports
- Cell Reversal From a Differentiated to a Stem-Like State at Cancer Initiation
- (2020) João Carvalho Frontiers in Oncology
- Current Trends in ATRA Delivery for Cancer Therapy
- (2020) Maria Valeria Giuli et al. Pharmaceutics
- Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
- (2020) Christopher Montemagno et al. Frontiers in Cell and Developmental Biology
- Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
- (2020) Hemant M. Kocher et al. Nature Communications
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing
- (2019) Jianming Pei et al. MODERN PATHOLOGY
- Retinoic acid signaling pathways
- (2019) Norbert B. Ghyselinck et al. DEVELOPMENT
- Lenvatinib in Management of Solid Tumors
- (2019) Zhonglin Hao et al. ONCOLOGIST
- Blockade of myeloid-derived suppressor cell expansion with all-trans retinoic acid increases the efficacy of anti-angiogenic therapy
- (2018) Raimund Bauer et al. CANCER RESEARCH
- Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
- (2018) Ahmed M.E. Abdalla et al. Theranostics
- Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma
- (2018) Joseph Mandelbaum et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The success and the challenge of all-trans retinoic acid in the treatment of cancer
- (2018) Xiaoling Ni et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials
- (2015) Patrick M. Dillon et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Apatinib for molecular targeted therapy in tumor
- (2015) Haijun Zhang Drug Design Development and Therapy
- Retinoic Acid Regulates Hematopoietic Development from Human Pluripotent Stem Cells
- (2015) Roger E. Rönn et al. Stem Cell Reports
- Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
- (2013) David J. Thomson et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Adenoid cystic carcinoma of the head and neck
- (2012) Christopher L. Ellington et al. CANCER
- The evolving concept of cancer and metastasis stem cells
- (2012) Irène Baccelli et al. JOURNAL OF CELL BIOLOGY
- Retinoids, Retinoic Acid Receptors, and Cancer
- (2011) Xiao-Han Tang et al. Annual Review of Pathology-Mechanisms of Disease
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- (2011) Shu Tian et al. CANCER SCIENCE
- Retinoid pathway and cancer therapeutics
- (2010) Nathan Bushue et al. ADVANCED DRUG DELIVERY REVIEWS
- Determinants and Patterns of Survival in Adenoid Cystic Carcinoma of the Head and Neck, Including an Analysis of Adjuvant Radiation Therapy
- (2010) Shane Lloyd et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
- (2010) Jin Li et al. BMC CANCER
- Nerve Growth Factor and Vascular Endothelial Growth Factor: Retrospective Analysis of 63 Patients with Salivary Adenoid Cystic Carcinoma
- (2010) Hao Li et al. International Journal of Oral Science
- Lung metastasis resection of adenoid cystic carcinoma of salivary glands☆
- (2008) Antonio Bobbio et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started